On this episode of MesoTV, our Patients Services Director, Julie White, RN, BSN, OCN, sits down with our new Executive Director, Brian Lepacek, MDiv, CAE, to discuss his role and how he got to the foundation. If you haven’t met Brian yet, definitely check out this episode to get to know him.
Adding immunotherapy to chemotherapy plus bevacizumab shows promising benefit in survival for non-epitheliod mesothelioma patients, but not across the board
The phase 3 clinical trial known as BEAT-meso, which combines chemotherapy plus bevacizumab with immunotherapy, has shown an improvement in overall survival (OS) and progression-free
